BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7212249)

  • 21. Etomidate and alfentanyl infusion for major surgery.
    Gepts E; Camu F
    Acta Anaesthesiol Belg; 1984 Sep; 35(3):246-7. PubMed ID: 6441437
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of etomidate associated with prolonged i.v. infusion.
    Hebron BS; Edbrooke DL; Newby DM; Mather SJ
    Br J Anaesth; 1983 Apr; 55(4):281-7. PubMed ID: 6340709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profile of etomidate. A hypnotic, anticonvulsant and brain protective compound.
    Wauquier A
    Anaesthesia; 1983 Jul; 38 Suppl():26-33. PubMed ID: 6346937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experiences with continuous infusions of etomidate in cardiac surgery (author's transl)].
    Blendinger I; Patschke D
    Anaesthesist; 1976 Aug; 25(8):391-2. PubMed ID: 949108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of etomidate on CSFP (author's transl)].
    Ekhart E; List WF
    Prakt Anaesth; 1978 Dec; 13(6):502-6. PubMed ID: 740631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model.
    Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ
    Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etomidate by infusion for neuroanaesthesia. Kinetic and dynamic interactions with nitrous oxide.
    Sear JW; Walters FJ; Wilkins DG; Willatts SM
    Anaesthesia; 1984 Jan; 39(1):12-8. PubMed ID: 6696212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat.
    Mandema JW; Wada DR
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1185-94. PubMed ID: 8531080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics as applied to total intravenous anaesthesia. Practical implications.
    Schüttler J; Schwilden H; Stoekel H
    Anaesthesia; 1983 Jul; 38 Suppl():53-6. PubMed ID: 6135368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etomidate infusion for laryngoscopy.
    Ewalenko P; Deloof T; Landreau MH; Vandesteene A; Reinhold H
    Acta Anaesthesiol Belg; 1981; 32(3):185-93. PubMed ID: 7304119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of etomidate infusions during anaesthesia for cardiopulmonary bypass.
    Oduro A; Tomlinson AA; Voice A; Davies GK
    Anaesthesia; 1983 Jul; 38 Suppl():66-9. PubMed ID: 6869760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat.
    Bol CJJG ; Danhof M; Stanski DR; Mandema JW
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1051-8. PubMed ID: 9399976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma concentrations of etomidate during an intravenous infusion over 48 hours.
    Hebron BS
    Anaesthesia; 1983 Jul; 38 Suppl():39-43. PubMed ID: 6869754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Etomidate as an anticonvulsive agent].
    Hoffmann P; Schockenhoff B
    Anaesthesist; 1984 Mar; 33(3):142-4. PubMed ID: 6721126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of etomidate in total intravenous anesthesia (TIVA).
    Helmers JH; Giezen J; Adam AA
    Acta Anaesthesiol Belg; 1981; 32(2):149-54. PubMed ID: 7293715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats.
    Pejo E; Ge R; Banacos N; Cotten JF; Husain SS; Raines DE
    Anesthesiology; 2012 May; 116(5):1057-65. PubMed ID: 22417966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of continuous infusion of etomidate in cirrhotic patients].
    Bonnardot JP; Levron JC; Deslauriers M; Brule ML; Flaisler B; Deligne P
    Ann Fr Anesth Reanim; 1991; 10(5):443-9. PubMed ID: 1755554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous pharmacokinetic profile in rats of etomidate, a short-acting hypnotic drug.
    Lewi PJ; Heykants JJ; Janssen PA
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):72-85. PubMed ID: 952578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of administration rate on propofol plasma-effect site equilibration.
    Struys MM; Coppens MJ; De Neve N; Mortier EP; Doufas AG; Van Bocxlaer JF; Shafer SL
    Anesthesiology; 2007 Sep; 107(3):386-96. PubMed ID: 17721240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.